Although cardiac glycosides decrease expression of prostate-specific antigen by down-regulation of prostate-derived Ets factor (Juang et al., 2010), digoxin treatment did not show conclusive anti-cancer effects on prostate cancer in previous conducted studies. Here, KLK3 is linked to cancer.